Led by $635m acquisition of Capsule Technologies, North America’s medical devices industry saw a rise of 34.83% in cross border deal activity during Q1 2021, when compared to the last four-quarter average, according to GlobalData’s deals database.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all
  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

 

A total of 60 cross border deals worth $2.25bn were announced for the region during Q1 2021, against the last four-quarter average of 44.50 deals.

Of all the deal types, venture financing saw most activity in Q1 2021 with 31 deals, representing a 51.7% share for the region.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

In second place was M&A with 23 deals, followed by private equity deals with six transactions, respectively capturing a 38.3% and 10% share of the overall cross border deal activity for the quarter.

In terms of value of cross border deals, M&A was the leading category in North America’s medical devices industry with $1.16bn, while venture financing and private equity deals totalled $715.46m and $369.67m, respectively.

North America medical devices industry cross border deals in Q1 2021: Top deals

The top five medical devices cross border deals accounted for a 53% share of the overall value during Q1 2021.

The combined value of the top five cross border deals stood at $1.19bn, against the overall value of $2.25bn recorded for the quarter.

The top five medical devices industry cross border deals of Q1 2021 tracked by GlobalData were:

1) Koninklijke Philips’ $635m acquisition of Capsule Technologies

2) The $240m acquisition of Alydia Health by Organon

3) Fidelity Management & Research and T Rowe Price Associates’ $115m private equity deal with Kardium

4) The $110m acquisition deal with 7D Surgical by SeaSpine

5) Altium Capital, Axiom Associates, Colle Capital Partners, GV Management Co, Huamin Investment Management and Nextrans’ venture financing with Hyperfine Research for $90m.